VCT220
A Study to Evaluate the Efficacy and Safety of VCT220 in Obesity Chinese Population
Vincentage Pharma Co · Phase 2 · Completed · Enrollment 250
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| 80mg dose group | n/r | n/r | n/r | n/r |
| 120mg dose group | n/r | n/r | n/r | n/r |
| 160mg dose group fast titration | n/r | n/r | n/r | n/r |
| 160mg dose group slow titration | n/r | n/r | n/r | n/r |
Not shown
- 80mg dose group: endpoint not reported
- 120mg dose group: endpoint not reported
- 160mg dose group fast titration: endpoint not reported
- 160mg dose group slow titration: endpoint not reported